ReachMD

Be part of the knowledge.™

Oncology - Hematology

65

LikeLikedUnlike

Episodes 1-13 of 13

- Jenn Simmons, MD
  Peer
- Clark C. Chen, MD, PhD
  Peer
- David Piccioni, MD, PHD
  Peer
- Christina I. Tsien, MD
  Peer
0
Medical Industry Feature
A Look at Current & Potential Therapies for High Grade Glioma
- Jennifer Caudle, DO
  Peer
- Daniel J. DeAngelo, MD, PhD
  Peer
4
Medical Industry Feature
Minimal Residual Disease & the Future of B-Cell ALL Treatment
- Matt Birnholz, MD
  Peer
- Ajai Chari, MD
  Peer
3
Medical Industry Feature
The BiTE® Immuno-Oncology Platform & Emerging Targets in Oncology
- Jeffrey V. Matous, MD
  Peer
1
$Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy$ $Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy$
Medical Industry Feature
Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy
- Joshua Richter, MD
  Peer
1
$Overall Survival Data in Patients with Relapsed/Refractory Multiple Myeloma$ $Overall Survival Data in Patients with Relapsed/Refractory Multiple Myeloma$
Medical Industry Feature
Overall Survival Data in Patients with Relapsed/Refractory Multiple Myeloma
- Sophie Balzora, MD, FACG
  Peer
- Carol A. Burke, MD, FACG, FASGE, AGAF, FACP
  Peer
6
Medical Industry Feature
Optimizing the Effectiveness of Colonoscopy for Colorectal Cancer Prevention:...
- Sophie Balzora, MD, FACG
  Peer
- Lawrence Hookey, MD
  Peer
6
Medical Industry Feature
Efficacy of a Next Generation Low Volume Bowel Prep
- Sophie Balzora, MD, FACG
  Peer
- Jonathan Cohen, MD
  Peer
5
Medical Industry Feature
Measuring Bowel Prep Efficacy: The Role of the Quality Assessment Scale
- Sophie Balzora, MD, FACG
  Peer
- Colleen M. Schmitt, MD, MHS, FASGE, FACG
  Peer
3
Medical Industry Feature
Enhancing the Patient Colonoscopy Journey: Factors That Can Influence the Pat...
- Heather McArthur, MD
  Peer
8
Medical Industry Feature
Breast Cancer: When May Neoadjuvant Therapy Be the Right Choice?
5
Medical Industry Feature
Neoantigens & Tumor Immunology: Learn More
- John J. Russell, MD
  Peer
- Philip A. Philip, MD, PhD, FRCP
  Peer
- Kurt Tauer, MD, FACP
  Peer
11
Medical Industry Feature
Metastatic Colorectal Cancer: A First-Line Treatment Approach to Wild-Type RA...
- John J. Russell, MD
  Peer
- Philip A. Philip, MD, PhD, FRCP
  Peer
- Kurt Tauer, MD, FACP
  Peer
12
Medical Industry Feature
The Evolution of Biomarker-Based Treatment in Metastatic Colorectal Cancer

Loading...

Programs 12/6/19

Playlist:

Recommended